Cite

    Luo, X., Hou, L., Zhong, Y., You, C., Yang, Y., Wu, X., Li, P., Zhou, S., Qiu, W., Zhang, H., Liu, Y., Qian, Y., Luo, F., Cheng, R., Hu, Y., Gong, H., Wang, Q., Xu, Z., Du, H., Lu, F., Fu, J., Chen, X., Wang, W., & Guo, Z. (2021). an open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children. Medicine, 100(51), e28158–. http://access.bl.uk/ark:/81055/vdc_100148071921.0x00003f